SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001209191-20-024107
Filing Date
2020-04-10
Accepted
2020-04-10 11:01:04
Documents
1
Effectiveness Date
2020-04-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13045
  Complete submission text file 0001209191-20-024107.txt   14142
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-364701 | Film No.: 20786178
SIC: 2836 Biological Products, (No Diagnostic Substances)